Clinical trial

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00662740

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Tiotropium/Salmeterol QD Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Salmeterol Normalized identity: salmeterolView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Tiotropium/Salmeterol QD+ Salmeterol Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Tiotropium (Spiriva®) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-04-15

PhasePHASE3

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

Tiotropium/Salmeterol QDDRUG

PlaceboDRUG

SalmeterolDRUG · verified · RxNorm: salmeterol

Tiotropium/Salmeterol QD+ SalmeterolDRUG

Tiotropium (Spiriva®)DRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

BerlinGermany4 SeoulSouth Korea3 RichmondVirginia, United States2 HamburgGermany2 HoustonTexas, United States1 San AntonioTexas, United States1 CincinnatiOhio, United States1 MarseilleFrance1 VancouverBritish Columbia, Canada1 MontpellierFrance1 BrusselsBelgium1 CalgaryAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00662740 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.